Sentence examples for mutation defined by from inspiring English sources

Conversely, a mutation defined by the TheraScreen assay in one sample could not be exclusively confirmed by the PyroMark assay.

If the mutation is deleterious, we assume that the penetrance of the mutation (defined by the probability of acquiring the disease before age t) is given by the known penetrance for BRCA1 or BRCA2, respectively.

χ was a factor of the type of mutation defined by GO, where the wild type and natural strains had no artificial gene deletion (0 as a dummy variable) but where the homozygous gene deletion strains did have a gene deletion (1 as a dummy variable).

Complementation testing and linkage analysis assigned 16 of the mutations defined by these 24 mutants to the same gene on linkage group (LG) I (chromosome I): all of the 16 mutations were recessive, and the affected strains constitutively expressed GST in the whole body without acrylamide.

Results from the GeneSV assessment of new mutations defined by comparison of 2 datasets 2012.02.12 and 2013.02.18 showed that from 1205 11700 codons + 35 bases) new mutations observed in updated DENV-2 genomic sequences, 1139 out of 1170 codon mutations (97%), and 29 out of 35 mutations from noncoding regions (83%) were predicted correctly as viable.

In our CF scenario, there is a list of possible mutation outcomes (MU) (i.e. all possible amino acids), a list of mutation positions (defined by the protein and the residue number) and the experimental ΔΔG values for some of the mutations at these positions.

Anbalagan and Xie [13] automated two pointcut-related mutation operators defined by Mortensen and Alexander [9].

A group of twelve right-handed presymptomatic gene mutation carriers defined by a positive gene test and absence of clinical symptoms (pHD, N = 12) from 22 to 52 years of age (M = 35.91; SD = 10.03) were recruited.

Unstratified estimated likelihood ratios (LRs) for predicting BRCA1 or BRCA2 mutation status defined by breast tumor ER-grade phenotype.

Unstratified estimated LRs for predicting BRCA1 or BRCA2 mutation status defined by breast tumor triple-negative phenotype.

IGHV mutation was defined by the presence of < 98% homology at sequencing and ZAP70 was defined as being positive if expressed in more than 20% of cells by flow cytometry.